Clinical Trial Update: Fraction Dose Escalation of Split-course Hypofractionated Concurrent Chemoradiotherapy Following Induction Chemo-immunotherapy in Unresectable Locally Advanced Esophageal Squamous Carcinoma: a Phase I Study. [Phase 1]

View source ↗

Summary

Phase I trial evaluating dose escalation of split-course hypofractionated concurrent chemoradiotherapy after induction chemo-immunotherapy in unresectable local…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING